ERK1/2 (Phospho-Thr202+Tyr204/Thr185+Tyr187) Antibody 12548 from Signalway Antibody LLC

Product Specs
ItemERK1/2 (Phospho-Thr202+Tyr204/Thr185+Tyr187) Antibody
CompanySignalway Antibody LLC
Price Pricing Info Supplier Page View Company Product Page
Catalog Number12548
Quantity50ul
ApplicationsWB
Concentration1.0mg/ml
Conjugate/TagUnconjugated
FormatRabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol
PurityAntibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide
ReactivityHu, Ms, Rt
Molecular Weight42,44
HostRabbit
ImmunogenPeptide
NCBI Full Gene Namemitogen-activated protein kinase 3, mitogen-activated protein kinase 1
NCBI Gene AliasesP44MAPK, p44-ERK1, ERK-2, p41, ERK, HUMKER1A, PRKM3, PRKM2, P44ERK1, p44-MAPK, MAPK2, NS13, ERK-1, p38, HS44KDAP, ERK1, ERK2, p40, p42-MAPK, P42MAPK, p41mapk, ERT1, PRKM1, ERT2
ClonalityPolyclonal
Domain/Region/TerminusA synthesized peptide derived from human ERK1/2 (Phospho-Thr202+Tyr204/Thr185+Tyr187)
TargetERK1/2
ValidationAs per applications, See images, contact for clarifications

Add to Compare List

Signalway Antibody LLC

6305 Ivy Lane, Suite 370

Greenbelt, Maryland 20770

United States

Phone: 1-301-446-2499
Fax: 1-301-446-2413

Email: info@signalwayantibody.com

Company Profile

Website: http://www.sabbiotech.com/

(1) TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer TreatmentInternational journal of molecular sciencesOctober 10, 2021Guo S, Bai X, Shi S, Deng Y, Kang X, An H.MEK1/2 (ab178876, Abcam), p-MEK1/2 (11205, Signalway, TX, USA), ERK1/2 (K200062M, Solarbio), p-ERK1/2 (12548, Signalway), cyclin D1 (60186-1-Ig, Proteintech, Chicago, IL, USA), cleaved-caspase 3 (AF7022, Affinity Biosciences

(2) TMEM16A-inhibitor loaded pH-responsive nanoparticles: A novel dual-targeting antitumor therapy for lung adenocarcinomaBiochemical pharmacologyAugust 1, 2020Guo S, Qiu L, Chen Y, Wang X, Ma B, Qu C, Cui J, Zhang H, Xing C, Zhan Y, et al.

Be the First to Write a Review!

ERK1/2 (Phospho-Thr202+Tyr204/Thr185+Tyr187) Antibody from Signalway Antibody LLC

Signalway Antibody LLC

Citations (2)

Reviews

ERK1/2 (Phospho-Thr202+Tyr204/Thr185+Tyr187) Antibody from Signalway Antibody LLC

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map